SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 27.18 |
| Enterprise Value ($M) | 20.43 |
| Book Value ($M) | -1.48 |
| Book Value / Share | -0.17 |
| Price / Book | -18.31 |
| NCAV ($M) | -4.60 |
| NCAV / Share | -0.54 |
| Price / NCAV | -5.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.82 |
| Return on Assets (ROA) | -0.14 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.14 |
| Current Ratio | 1.14 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 14.95 |
| Assets | 18.06 |
| Liabilities | 19.54 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,605 | 20,402 | 17.67 | |
| 4,309 | 35,060 | 12.29 | |
| 17,429 | 44,034 | 39.58 | |
| 6,570 | 101,172 | 6.49 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CYCN – Cyclerion Therapeutics, Inc. | CYRX – Cryoport, Inc. |
| CYTH – Cyclo Therapeutics, Inc. | DERM – Journey Medical Corporation |
| DMAC – DiaMedica Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io